If miR-29b was overexpressed in the remaining cervical cancer cells after radiotherapy, it will significantly inhibit the expression of PTEN, activate the AKT signal pathway and inhibit DSB, and enhance the sensitivity to radiotherapy 193, 194. The gene discussed is PTEN; the disease is cervical carcinoma.